Roquette expands healthcare portfolio at Vitafoods Europe

healthcare

Prime Highlights-

  • Roquette will present its expanded consumer healthcare solutions portfolio at Vitafoods Europe.
  • The portfolio supports capsules, gummies, softgels, and other health product formats.

Key Facts-

  • Roquette is a global leader in plant-based ingredients and pharmaceutical solutions.
  • The company operates in more than 150 countries with over 11,000 employees.

Background-

Roquette will showcase its expanded consumer healthcare portfolio at Vitafoods Europe in May, highlighting its growing presence in plant-based health and pharmaceutical solutions.

The company said its broadened portfolio is designed to help consumer healthcare brands, over-the-counter product makers, and contract development and manufacturing organizations accelerate innovation and meet rising consumer demand for clean-label, effective, and easy-to-use health products.

Roquette will present solutions across multiple dosage formats, including hard and softgel capsules, gummies, chewables, and mini tablets. The offering is aimed at supporting customers from product concept through to commercial launch, with a focus on speed to market and regulatory readiness.

The company’s expanded portfolio now includes technologies added through recent acquisitions, such as hard capsules and advanced softgel and gummy solutions. It said these capabilities will help brands develop products that meet diverse dietary requirements, including vegan, halal, and kosher standards.

Roquette will also highlight formulation solutions focused on taste, mouthfeel, texture, and controlled release performance, areas that have become increasingly important in consumer healthcare and dietary supplements.

The showcase reflects the company’s continued investment in plant-based and sustainable healthcare solutions as competition intensifies in the global wellness and OTC market.

With operations in more than 150 countries and over 11,000 employees worldwide, Roquette said it remains focused on supporting innovation in nutrition, health, and bioindustry through long-term technical partnerships and commercial solutions.

Read Also: Pathogen Benefit-Sharing Deadlock Persists as WHO Deadline Looms

Share:

Facebook
Twitter
WhatsApp
LinkedIn